Cargando…

Psychometric Properties of the Persian Version of Cystic Fibrosis Questionnaire: Revised in Children with Cystic Fibrosis

BACKGROUND: Cystic fibrosis is a progressive, fatal disease affecting the quality of life. The cystic fibrosis questionnaire-revised (CFQ-R) is an efficient tool to monitor health-related quality of life in patients. The aim of this study was to explore the psychometric properties of the child and p...

Descripción completa

Detalles Bibliográficos
Autores principales: Havaei, Naser, Modaresi, Mohammad Reza, Rezaei, Mandana, Asghari-Jafarabadi, Mohammad, Kohzadi, Ameneh, Ariafar, Yalda, Ghalibaf, Babak, Goljaryan, Sakineh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580193/
https://www.ncbi.nlm.nih.gov/pubmed/37855002
http://dx.doi.org/10.4103/ijpvm.ijpvm_137_22
_version_ 1785121895246462976
author Havaei, Naser
Modaresi, Mohammad Reza
Rezaei, Mandana
Asghari-Jafarabadi, Mohammad
Kohzadi, Ameneh
Ariafar, Yalda
Ghalibaf, Babak
Goljaryan, Sakineh
author_facet Havaei, Naser
Modaresi, Mohammad Reza
Rezaei, Mandana
Asghari-Jafarabadi, Mohammad
Kohzadi, Ameneh
Ariafar, Yalda
Ghalibaf, Babak
Goljaryan, Sakineh
author_sort Havaei, Naser
collection PubMed
description BACKGROUND: Cystic fibrosis is a progressive, fatal disease affecting the quality of life. The cystic fibrosis questionnaire-revised (CFQ-R) is an efficient tool to monitor health-related quality of life in patients. The aim of this study was to explore the psychometric properties of the child and parent versions of the Persian version of the CFQ-R in the Iranian population. METHODS: Fifty children with cystic fibrosis (6–11 years) and their parents were allocated in this methodological study to examine convergent validity, discriminant validity, test-retest reliability (n = 30), internal consistency, ceiling and floor effects, and agreement between two versions of the CFQ-R. RESULTS: Convergent validity was confirmed for parent proxy (P < 0.05). CFQ-R discriminated patients among stages of disease severity based on lung function, age, and BMI (P < 0.05). Test-retest analysis revealed good to excellent reliability (inter-class correlation coefficient (ICC) = 0.78–0.97). In most domains, lower quality of life scores was obtained in the parent proxy compared to the child version (P < 0.05). Domain-specific correlations were found between the child version and parent proxy (P < 0.05). Internal consistency was generally confirmed (α = 0.13–0.83 in child version and α = 0.25–0.87 in parent proxy). There were no floor effects. Ceiling effects were mostly seen for physical, digestion, and body image domains in the child version and for eating, weight, and school domains in the parent proxy. CONCLUSIONS: The child version and parent proxy of the Persian CFQ-R are valid and reliable measures and can be applied in clinical trials to monitor the quality of life in children with cystic fibrosis. It is recommended to use both versions in conjunction to better interpret the quality of life aspects of children with cystic fibrosis.
format Online
Article
Text
id pubmed-10580193
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-105801932023-10-18 Psychometric Properties of the Persian Version of Cystic Fibrosis Questionnaire: Revised in Children with Cystic Fibrosis Havaei, Naser Modaresi, Mohammad Reza Rezaei, Mandana Asghari-Jafarabadi, Mohammad Kohzadi, Ameneh Ariafar, Yalda Ghalibaf, Babak Goljaryan, Sakineh Int J Prev Med Original Article BACKGROUND: Cystic fibrosis is a progressive, fatal disease affecting the quality of life. The cystic fibrosis questionnaire-revised (CFQ-R) is an efficient tool to monitor health-related quality of life in patients. The aim of this study was to explore the psychometric properties of the child and parent versions of the Persian version of the CFQ-R in the Iranian population. METHODS: Fifty children with cystic fibrosis (6–11 years) and their parents were allocated in this methodological study to examine convergent validity, discriminant validity, test-retest reliability (n = 30), internal consistency, ceiling and floor effects, and agreement between two versions of the CFQ-R. RESULTS: Convergent validity was confirmed for parent proxy (P < 0.05). CFQ-R discriminated patients among stages of disease severity based on lung function, age, and BMI (P < 0.05). Test-retest analysis revealed good to excellent reliability (inter-class correlation coefficient (ICC) = 0.78–0.97). In most domains, lower quality of life scores was obtained in the parent proxy compared to the child version (P < 0.05). Domain-specific correlations were found between the child version and parent proxy (P < 0.05). Internal consistency was generally confirmed (α = 0.13–0.83 in child version and α = 0.25–0.87 in parent proxy). There were no floor effects. Ceiling effects were mostly seen for physical, digestion, and body image domains in the child version and for eating, weight, and school domains in the parent proxy. CONCLUSIONS: The child version and parent proxy of the Persian CFQ-R are valid and reliable measures and can be applied in clinical trials to monitor the quality of life in children with cystic fibrosis. It is recommended to use both versions in conjunction to better interpret the quality of life aspects of children with cystic fibrosis. Wolters Kluwer - Medknow 2023-06-22 /pmc/articles/PMC10580193/ /pubmed/37855002 http://dx.doi.org/10.4103/ijpvm.ijpvm_137_22 Text en Copyright: © 2023 International Journal of Preventive Medicine https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Havaei, Naser
Modaresi, Mohammad Reza
Rezaei, Mandana
Asghari-Jafarabadi, Mohammad
Kohzadi, Ameneh
Ariafar, Yalda
Ghalibaf, Babak
Goljaryan, Sakineh
Psychometric Properties of the Persian Version of Cystic Fibrosis Questionnaire: Revised in Children with Cystic Fibrosis
title Psychometric Properties of the Persian Version of Cystic Fibrosis Questionnaire: Revised in Children with Cystic Fibrosis
title_full Psychometric Properties of the Persian Version of Cystic Fibrosis Questionnaire: Revised in Children with Cystic Fibrosis
title_fullStr Psychometric Properties of the Persian Version of Cystic Fibrosis Questionnaire: Revised in Children with Cystic Fibrosis
title_full_unstemmed Psychometric Properties of the Persian Version of Cystic Fibrosis Questionnaire: Revised in Children with Cystic Fibrosis
title_short Psychometric Properties of the Persian Version of Cystic Fibrosis Questionnaire: Revised in Children with Cystic Fibrosis
title_sort psychometric properties of the persian version of cystic fibrosis questionnaire: revised in children with cystic fibrosis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580193/
https://www.ncbi.nlm.nih.gov/pubmed/37855002
http://dx.doi.org/10.4103/ijpvm.ijpvm_137_22
work_keys_str_mv AT havaeinaser psychometricpropertiesofthepersianversionofcysticfibrosisquestionnairerevisedinchildrenwithcysticfibrosis
AT modaresimohammadreza psychometricpropertiesofthepersianversionofcysticfibrosisquestionnairerevisedinchildrenwithcysticfibrosis
AT rezaeimandana psychometricpropertiesofthepersianversionofcysticfibrosisquestionnairerevisedinchildrenwithcysticfibrosis
AT asgharijafarabadimohammad psychometricpropertiesofthepersianversionofcysticfibrosisquestionnairerevisedinchildrenwithcysticfibrosis
AT kohzadiameneh psychometricpropertiesofthepersianversionofcysticfibrosisquestionnairerevisedinchildrenwithcysticfibrosis
AT ariafaryalda psychometricpropertiesofthepersianversionofcysticfibrosisquestionnairerevisedinchildrenwithcysticfibrosis
AT ghalibafbabak psychometricpropertiesofthepersianversionofcysticfibrosisquestionnairerevisedinchildrenwithcysticfibrosis
AT goljaryansakineh psychometricpropertiesofthepersianversionofcysticfibrosisquestionnairerevisedinchildrenwithcysticfibrosis